VCEL Q3 2018 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M+57.7% YoY

Gross Profit

$14M63.8% margin

Operating Income

-$1M-5.9% margin

Net Income

-$1M-4.8% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

+18.3%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$891,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$124M

Total Liabilities

$30M

Stockholders' Equity

$94M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$14M	+57.7%
Gross Profit	$14M	$7M	+102.8%
Operating Income	-$1M	-$4M	+66.9%
Net Income	-$1M	-$5M	+80.2%

Revenue Segments

Product

$22M100%